JT001 (VV116) for the Early Treatment of COVID-19

Clinical trial NCT05242042 · TERMINATED

Trial details

NCT number: NCT05242042
Sponsor: Shanghai JunTop Biosciences Co., LTD
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Mild to Moderate COVID-19

Start date: 2022-01-28
Primary completion: 2023-03-23
Enrollment: 381

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.